Kirby P Gardner is an Associate Research Scientist at Creatv Microtech, Inc. and graduate student at Rutgers University. He obtained his B.S. in Biology from The College of New Jersey in 2017 and is anticipated to finish his Master of Biomedical Science degree from Rutgers School of Graduate Studies in August 2022. At Creatv, he has published works in npj Precision Oncology & PLOS ONE, both pertaining to giant polyploid myeloid cells (i.e., CAMLs) in pancreatic adenocarcinoma. He has also presented at conferences such as ASCO, AACR, and EDRN. He currently holds a student membership with ASCO. His current research interest is in the liquid biopsy oncology field, specifically in the tracking of tumor-associated cells in solid tumor malignancies. He also studies cellular mechanisms in CAMLs such as phagocytic engorgement and cell motility biomarkers, as well as exosome and micronuclei formation in relation to disease progression and overall survival.
Rutgers, The State University of New Jersey
New Brunswick, New Jersey, USA